{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:35:18Z","timestamp":1769808918506,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.1038\/s41416-025-03272-2","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:43:05Z","timestamp":1765881785000},"page":"567-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness"],"prefix":"10.1038","volume":"134","author":[{"given":"Shunta","family":"Tsuchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Taki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Tane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Samejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiju","family":"Aokage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Sasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-0189","authenticated-orcid":false,"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8637-3323","authenticated-orcid":false,"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"3272_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/path.1700330302","volume":"33","author":"RA Willis","year":"1930","unstructured":"Willis RA. Epidermoid carcinoma of the head and neck, with special reference to metastasis. J Pathol Bacteriol. 1930;33:501\u201326. https:\/\/doi.org\/10.1002\/path.1700330302.","journal-title":"J Pathol Bacteriol"},{"key":"3272_CR2","doi-asserted-by":"publisher","unstructured":"Klarica Gembi\u0107 T, Grebi\u0107 D, Guli\u0107 T, Golemac M, Avirovi\u0107 M. Predictive and prognostic values of glycoprotein 96, androgen receptors, and extranodal extension in sentinel lymph node-positive breast cancer. J Clin Med. 2024;13. https:\/\/doi.org\/10.3390\/jcm13247665.","DOI":"10.3390\/jcm13247665"},{"key":"3272_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10120-008-0473-8","volume":"11","author":"T Okamoto","year":"2008","unstructured":"Okamoto T, Tsuburaya A, Kameda Y, Yoshikawa T, Cho H, Tsuchida K, et al. Prognostic value of extracapsular invasion and fibrotic focus in single lymph node metastasis of gastric cancer. Gastric Cancer. 2008;11:160\u20137. https:\/\/doi.org\/10.1007\/s10120-008-0473-8.","journal-title":"Gastric Cancer"},{"key":"3272_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/cncr.24764","volume":"116","author":"H Alakus","year":"2010","unstructured":"Alakus H, H\u00f6lscher AH, Grass G, Hartmann E, Schulte C, Drebber U, et al. Extracapsular lymph node spread: a new prognostic factor in gastric cancer. Cancer. 2010;116:309\u201315. https:\/\/doi.org\/10.1002\/cncr.24764.","journal-title":"Cancer"},{"key":"3272_CR5","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1245\/s10434-020-08546-y","volume":"27","author":"B Li","year":"2020","unstructured":"Li B, Lo AWI, Law S. ASO author reflections: Extracapsular extension of lymph node: An important consideration for gastric cancer. Ann Surg Oncol. 2020;27:4233\u20134. https:\/\/doi.org\/10.1245\/s10434-020-08546-y.","journal-title":"Ann Surg Oncol"},{"key":"3272_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jhbp.12008","volume":"31","author":"MK Sung","year":"2024","unstructured":"Sung MK, Chun J, Park Y, Kwak BJ, Lee W, Song KB, et al. Extranodal extension influences prognosis in pancreatic body\/tail cancer: a retrospective cohort study. J Hepatobiliary Pancreat Sci. 2024;31:569\u201380. https:\/\/doi.org\/10.1002\/jhbp.12008.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3272_CR7","doi-asserted-by":"publisher","unstructured":"Luchini C, Fleischmann A, Boormans JL, Fassan M, Nottegar A, Lucato P, et al. Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis. Sci Rep. 2017;7. https:\/\/doi.org\/10.1038\/s41598-017-02577-4.","DOI":"10.1038\/s41598-017-02577-4"},{"key":"3272_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/annonc\/mdv494","volume":"27","author":"N Veronese","year":"2016","unstructured":"Veronese N, Nottegar A, Pea A, Solmi M, Stubbs B, Capelli P, et al. Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis. Ann Oncol. 2016;27:42\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdv494.","journal-title":"Ann Oncol"},{"key":"3272_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00428-018-2309-1","volume":"472","author":"C Luchini","year":"2018","unstructured":"Luchini C, Veronese N, Nottegar A, Cheng M, Kaneko T, Pilati C, et al. Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis. Virchows Arch. 2018;472:939\u201347. https:\/\/doi.org\/10.1007\/s00428-018-2309-1.","journal-title":"Virchows Arch"},{"key":"3272_CR10","doi-asserted-by":"publisher","unstructured":"Detterbeck FC, Woodard GA, Bader AS, Dacic S, Grant MJ, Park HS, et al. The proposed 9th edition TNM classification of lung cancer. Chest. 2024. https:\/\/doi.org\/10.1016\/j.chest.2024.05.026.","DOI":"10.1016\/j.chest.2024.05.026"},{"key":"3272_CR11","first-page":"6287","volume":"8","author":"W Liu","year":"2015","unstructured":"Liu W, Shao Y, Guan B, Hao J, Cheng X, Ji K, et al. Extracapsular extension is a powerful prognostic factor in stage IIA\u2013IIIA non-small cell lung cancer patients with complete resection. Int J Clin Exp Pathol. 2015;8:6287\u201393.","journal-title":"Int J Clin Exp Pathol"},{"key":"3272_CR12","doi-asserted-by":"publisher","unstructured":"Shih BC, Jeon JH, Chung JH, Kwon HJ, Lee JH, Jung W, et al. Prognostic significance of the extranodal extension of regional lymph nodes in stage III-N2 non-small-cell lung cancer after curative resection. J Clin Med. 2021;10. https:\/\/doi.org\/10.3390\/jcm10153324.","DOI":"10.3390\/jcm10153324"},{"key":"3272_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jtho.2023.08.003","volume":"19","author":"H Xie","year":"2024","unstructured":"Xie H, Dai C, Gu C, Zhao S, Xu L, Wang F, et al. Validation of the proposed IASLC residual tumor classification to upgrade extracapsular extension of tumor in nodes from R0 to incomplete resection. J Thorac Oncol. 2024;19:130\u201340. https:\/\/doi.org\/10.1016\/j.jtho.2023.08.003.","journal-title":"J Thorac Oncol"},{"key":"3272_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1378\/chest.06-1810","volume":"131","author":"YC Lee","year":"2007","unstructured":"Lee YC, Wu CT, Kuo SW, Tseng YT, Chang YL. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest. 2007;131:993\u20139. https:\/\/doi.org\/10.1378\/chest.06-1810.","journal-title":"Chest"},{"key":"3272_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"3272_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","volume":"99","author":"G Ishii","year":"2016","unstructured":"Ishii G, Ochiai A, Neri S. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv Drug Deliv Rev. 2016;99:186\u201396. https:\/\/doi.org\/10.1016\/j.addr.2015.07.007.","journal-title":"Adv Drug Deliv Rev"},{"key":"3272_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fonc.2018.00036","volume":"8","author":"D Jones","year":"2018","unstructured":"Jones D, Pereira ER, Padera TP. Growth and immune evasion of lymph node metastasis. Front Oncol. 2018;8:36 https:\/\/doi.org\/10.3389\/fonc.2018.00036.","journal-title":"Front Oncol"},{"key":"3272_CR18","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.7150\/thno.82700","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Li M, Su K, Zong S, Zhang H, Xiong L, et al. Pre-metastatic niche: From revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis. Theranostics. 2023;13:2301\u201318. https:\/\/doi.org\/10.7150\/thno.82700.","journal-title":"Theranostics"},{"key":"3272_CR19","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s00432-021-03608-4","volume":"147","author":"K Nomura","year":"2021","unstructured":"Nomura K, Aokage K, Nakai T, Sakashita S, Miyoshi T, Tane K, et al. Prognostic impact of extranodal extension in patients with pN1\u2013N2 lung adenocarcinoma. J Cancer Res Clin Oncol. 2021;147:3699\u2013707. https:\/\/doi.org\/10.1007\/s00432-021-03608-4.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3272_CR20","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/cas.15266","volume":"113","author":"K Nomura","year":"2022","unstructured":"Nomura K, Nakai T, Nishina Y, Sakamoto N, Miyoshi T, Tane K, et al. 18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma. Cancer Sci. 2022;113:1488\u201396. https:\/\/doi.org\/10.1111\/cas.15266.","journal-title":"Cancer Sci"},{"key":"3272_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00432-015-2046-7","volume":"142","author":"S Neri","year":"2016","unstructured":"Neri S, Hashimoto H, Kii H, Watanabe H, Masutomi K, Kuwata T, et al. Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts. J Cancer Res Clin Oncol. 2016;142:437\u201346. PMID:26374424.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3272_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jop.12870","volume":"48","author":"AE Pilborough","year":"2019","unstructured":"Pilborough AE, Lambert DW, Khurram SA. Extranodal extension in oral cancer: a role for the nodal microenvironment?. J Oral Pathol Med. 2019;48:863\u201370. https:\/\/doi.org\/10.1111\/jop.12870.","journal-title":"J Oral Pathol Med"},{"key":"3272_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476365","volume":"15","author":"Q Yan","year":"2024","unstructured":"Yan Q, Li S, He L, Chen N. Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis. Front Immunol. 2024;15:1476365. https:\/\/doi.org\/10.3389\/fimmu.2024.1476365.","journal-title":"Front Immunol"},{"key":"3272_CR24","doi-asserted-by":"publisher","unstructured":"Lv T, Fan R, Wu J, Gong H, Gao X, Liu X, et al. Tumor-associated macrophages: key players in the non-small cell lung cancer tumor microenvironment. Cancer Med. 2025;14. https:\/\/doi.org\/10.1002\/cam4.70670","DOI":"10.1002\/cam4.70670"},{"key":"3272_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, R\u00fcschoff JH, Moch H, de Souza N, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024;42:396\u2013412.e5. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.021.","journal-title":"Cancer Cell"},{"key":"3272_CR26","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1245\/s10434-012-2421-4","volume":"19","author":"S Neri","year":"2012","unstructured":"Neri S, Ishii G, Taira T, Hishida T, Yoshida J, Nishimura M, et al. Recruitment of podoplanin-positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma. Ann Surg Oncol. 2012;19:3953\u201362. https:\/\/doi.org\/10.1245\/s10434-012-2421-4.","journal-title":"Ann Surg Oncol"},{"key":"3272_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2017.02.026","volume":"395","author":"S Neri","year":"2017","unstructured":"Neri S, Miyashita T, Hashimoto H, Suda Y, Ishibashi M, Kii H, et al. Fibroblast-led cancer cell invasion is activated by epithelial\u2013mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma. Cancer Lett. 2017;395:20\u201330. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.026.","journal-title":"Cancer Lett"},{"key":"3272_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0003-4975(97)00314-7","volume":"63","author":"JF Vansteenkiste","year":"1997","unstructured":"Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg. 1997;63:1174\u201382.","journal-title":"Ann Thorac Surg"},{"key":"3272_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt WM, Patel SG, O\u2019Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122\u201337. https:\/\/doi.org\/10.3322\/caac.21389.","journal-title":"CA Cancer J Clin"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03272-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03272-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03272-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:55:02Z","timestamp":1769770502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03272-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,20]]}},"alternative-id":["3272"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03272-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Nomura has received honoraria for lectures from AstraZeneca, Chugai Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd.; honoraria for manuscript writing from Taiho Pharmaceutical Co., Ltd., Nipponrinshosha Co., Ltd., and MedPeer, Inc.; and support for attending meetings and travel from the Chugai Foundation for Innovative Drug Discovery Science. Dr. Wakabayashi has received honoraria for lectures from Nihon Medi-Physics Co., Ltd. Dr. Samejima has received honoraria for presentations from Johnson & Johnson, Osaka Chamber of Commerce and Industry, MiRXES Japan, Taiho Pharmaceutical Co., Ltd., Ziosoft, Olympus, and Japan Blood Products Organization. Dr. Aokage has received honoraria for lectures and\/or manuscript writing from various pharmaceutical and medical companies, including AstraZeneca, Chugai, Daiichi Sankyo, Taiho, and others. Dr. Tsuboi has received honoraria for lectures from Johnson & Johnson, AstraZeneca, Chugai, and other pharmaceutical companies. Dr. Ishii has received honoraria for lectures from Roche Diagnostics, Chugai, Novartis, and others. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the National Cancer Center Hospital East (approval numbers: 2020-147, 2020-226, and 2024-048), and was conducted in accordance with the Declaration of Helsinki. Comprehensive informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}